The mRNA expression of selected stem and progenitor genes (NANOG, INS, CK19) in peripheral-blood mononuclear cells has potential as a valuable marker for pancreatic cancer, with a notable correlation with coexisting inflammation. This evidence concerns the gene KRT19 and familial pancreatic carcinoma.